Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase

Documenti analoghi

• Absolute oral bioavailability of milvexian spray‐dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach
  di: Praneeth Jarugula, et al.
  Pubblicazione: (2024)
• Drug–Drug Interaction Potential of Mavacamten with Midazolam: Combined Results from Clinical and Model‐Based Studies
  di: Samira Merali, et al.
  Pubblicazione: (2024)
• Risk Factors Influencing Survival in T‐Cell Lymphoblastic Lymphoma and T‐Cell Acute Lymphoblastic Leukemia
  di: Tong Yoon Kim, et al.
  Pubblicazione: (2025)
• Patients First: Navigating Asparaginase‐Based Treatment in Young Adults With Acute Lymphoblastic Leukemia
  di: Ryan D. Cassaday, et al.
  Pubblicazione: (2026)
• Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
  di: Alda Daniela García‐Guzmán, et al.
  Pubblicazione: (2025)